NO20054136L - Imidazol-4-yl-etynyl-pyridin-derivater - Google Patents
Imidazol-4-yl-etynyl-pyridin-derivaterInfo
- Publication number
- NO20054136L NO20054136L NO20054136A NO20054136A NO20054136L NO 20054136 L NO20054136 L NO 20054136L NO 20054136 A NO20054136 A NO 20054136A NO 20054136 A NO20054136 A NO 20054136A NO 20054136 L NO20054136 L NO 20054136L
- Authority
- NO
- Norway
- Prior art keywords
- imidazol
- pyridine derivatives
- ylethynyl
- disease
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03004952 | 2003-03-10 | ||
| PCT/EP2004/002276 WO2004080998A1 (en) | 2003-03-10 | 2004-03-05 | Imidazol-4-yl-ethynyl-pyridine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054136D0 NO20054136D0 (no) | 2005-09-06 |
| NO20054136L true NO20054136L (no) | 2005-09-26 |
Family
ID=32981724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054136A NO20054136L (no) | 2003-03-10 | 2005-09-06 | Imidazol-4-yl-etynyl-pyridin-derivater |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7153874B2 (ru) |
| EP (1) | EP1606277B8 (ru) |
| JP (1) | JP4404896B2 (ru) |
| KR (1) | KR100742019B1 (ru) |
| CN (1) | CN100358889C (ru) |
| AR (1) | AR043501A1 (ru) |
| AT (1) | ATE395345T1 (ru) |
| AU (1) | AU2004220382B2 (ru) |
| BR (1) | BRPI0408093A (ru) |
| CA (1) | CA2516682C (ru) |
| CL (1) | CL2004000449A1 (ru) |
| CO (1) | CO5601027A2 (ru) |
| DE (1) | DE602004013746D1 (ru) |
| DK (1) | DK1606277T3 (ru) |
| ES (1) | ES2305739T3 (ru) |
| HK (1) | HK1089443A1 (ru) |
| HR (1) | HRP20050774A2 (ru) |
| IL (1) | IL170129A (ru) |
| MX (1) | MXPA05009524A (ru) |
| MY (1) | MY135491A (ru) |
| NO (1) | NO20054136L (ru) |
| NZ (1) | NZ541643A (ru) |
| PA (1) | PA8597301A1 (ru) |
| PE (1) | PE20041061A1 (ru) |
| PL (1) | PL1606277T3 (ru) |
| PT (1) | PT1606277E (ru) |
| RU (1) | RU2342383C2 (ru) |
| SI (1) | SI1606277T1 (ru) |
| TW (1) | TWI292318B (ru) |
| WO (1) | WO2004080998A1 (ru) |
| ZA (1) | ZA200506834B (ru) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7452909B2 (en) * | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
| RS50603B (sr) * | 2004-06-01 | 2010-05-07 | F. Hoffmann-La Roche Ag. | Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora |
| KR100907108B1 (ko) | 2004-06-01 | 2009-07-09 | 에프. 호프만-라 로슈 아게 | Ｍｇｌｕ5 수용체 길항제로서 피리딘-4-일-에틴일-이미다졸및 피라졸 |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| DE102006011574A1 (de) * | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| CN101568531B (zh) | 2006-12-21 | 2013-11-13 | 弗·哈夫曼-拉罗切有限公司 | Mglur5受体拮抗剂的多晶型物 |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US8334287B2 (en) * | 2009-07-17 | 2012-12-18 | Hoffmann-La Roche Inc. | Imidazoles |
| US8586581B2 (en) * | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
| PT2702051E (pt) | 2011-04-26 | 2015-05-20 | Hoffmann La Roche | Derivados de etinilo como reguladores alostéricos positivos de rmglu5 |
| UA116023C2 (uk) | 2013-07-08 | 2018-01-25 | Ф. Хоффманн-Ля Рош Аг | Етинільні похідні як антагоністи метаботропного глутаматного рецептора |
| US10941132B2 (en) | 2016-01-05 | 2021-03-09 | Hua Medicine (Shanghai) Ltd. | Pyrazole derivatives |
| AR113206A1 (es) | 2017-01-10 | 2020-02-19 | Bayer Cropscience Ag | Derivados heterocíclicos como pesticidas |
| AU2018207776B2 (en) | 2017-01-10 | 2021-06-17 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
| EP4069685A1 (en) * | 2019-12-02 | 2022-10-12 | F. Hoffmann-La Roche AG | Alkynyl-(heteroaryl)-carboxamide hcn1 inhibitors |
| CN111416154B (zh) * | 2020-05-22 | 2021-08-06 | 松山湖材料实验室 | 高电压锂离子电池电解液硅基吡啶添加剂、电解液及其电池 |
| AU2022251771A1 (en) | 2021-03-27 | 2023-09-21 | Syngenta Crop Protection Ag | Microbiocidal isonicotinic amide derivatives |
| WO2023089049A2 (en) | 2021-11-19 | 2023-05-25 | Syngenta Crop Protection Ag | Microbiocidal isonicotinic amide derivatives |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3303199A (en) * | 1963-07-15 | 1967-02-07 | Geigy Chem Corp | Certain imidazolone derivatives and process for making same |
| US3341548A (en) * | 1964-04-29 | 1967-09-12 | Hoffmann La Roche | Nitroimidazoles and their preparation |
| DE2035905A1 (de) | 1970-07-20 | 1972-02-03 | Chemische Fabrik Stockhausen & Cie.,4150Krefeld | Imidazolverbindungen und deren Herstellungsverfahren |
| CA1174673A (en) | 1981-02-27 | 1984-09-18 | Walter Hunkeler | Imidazodiazepines |
| US4711962A (en) * | 1984-10-18 | 1987-12-08 | Stauffer Chemical Company | Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles |
| US4882343A (en) * | 1987-08-28 | 1989-11-21 | G. D. Searle & Co. | Biarylalkylimidazole derivatives as anti-depressants |
| ES2084702T3 (es) | 1989-06-30 | 1996-05-16 | Du Pont | Imidazoles sustituidos utiles como inhibidores de la angiotensina ii. |
| TW544448B (en) | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| YU6100A (sh) | 1997-08-14 | 2002-10-18 | F.Hoffmann-La Roche Ag. | Heterociklični viniletri protiv neuroloških poremećaja |
| JP4815083B2 (ja) | 1999-08-31 | 2011-11-16 | メルク・シャープ・エンド・ドーム・コーポレイション | 複素環化合物およびそれの使用方法 |
| BR0115871A (pt) | 2000-12-04 | 2003-10-28 | Hoffmann La Roche | Derivados de feniletenila ou feniletinila como antagonistas de receptores de glutamato |
| CA2470612A1 (en) * | 2001-12-19 | 2003-07-03 | Merck & Co., Inc. | Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
-
2004
- 2004-03-04 TW TW093105737A patent/TWI292318B/zh not_active IP Right Cessation
- 2004-03-05 SI SI200430735T patent/SI1606277T1/sl unknown
- 2004-03-05 KR KR1020057016753A patent/KR100742019B1/ko not_active IP Right Cessation
- 2004-03-05 MX MXPA05009524A patent/MXPA05009524A/es active IP Right Grant
- 2004-03-05 AT AT04717578T patent/ATE395345T1/de active
- 2004-03-05 CA CA002516682A patent/CA2516682C/en not_active Expired - Fee Related
- 2004-03-05 RU RU2005131165/04A patent/RU2342383C2/ru not_active IP Right Cessation
- 2004-03-05 CN CNB2004800065725A patent/CN100358889C/zh not_active Expired - Fee Related
- 2004-03-05 PL PL04717578T patent/PL1606277T3/pl unknown
- 2004-03-05 PT PT04717578T patent/PT1606277E/pt unknown
- 2004-03-05 BR BRPI0408093-9A patent/BRPI0408093A/pt not_active IP Right Cessation
- 2004-03-05 DK DK04717578T patent/DK1606277T3/da active
- 2004-03-05 JP JP2006504558A patent/JP4404896B2/ja not_active Expired - Fee Related
- 2004-03-05 WO PCT/EP2004/002276 patent/WO2004080998A1/en active IP Right Grant
- 2004-03-05 ES ES04717578T patent/ES2305739T3/es not_active Expired - Lifetime
- 2004-03-05 AU AU2004220382A patent/AU2004220382B2/en not_active Ceased
- 2004-03-05 NZ NZ541643A patent/NZ541643A/en unknown
- 2004-03-05 EP EP04717578A patent/EP1606277B8/en not_active Expired - Lifetime
- 2004-03-05 DE DE602004013746T patent/DE602004013746D1/de not_active Expired - Lifetime
- 2004-03-05 PA PA20048597301A patent/PA8597301A1/es unknown
- 2004-03-08 US US10/795,619 patent/US7153874B2/en not_active Expired - Fee Related
- 2004-03-08 AR ARP040100722A patent/AR043501A1/es not_active Application Discontinuation
- 2004-03-08 CL CL200400449A patent/CL2004000449A1/es unknown
- 2004-03-08 PE PE2004000252A patent/PE20041061A1/es not_active Application Discontinuation
- 2004-03-09 MY MYPI20040806A patent/MY135491A/en unknown
-
2005
- 2005-08-04 IL IL170129A patent/IL170129A/en not_active IP Right Cessation
- 2005-08-25 ZA ZA200506834A patent/ZA200506834B/en unknown
- 2005-08-25 CO CO05085015A patent/CO5601027A2/es active IP Right Grant
- 2005-09-05 HR HR20050774A patent/HRP20050774A2/xx not_active Application Discontinuation
- 2005-09-06 NO NO20054136A patent/NO20054136L/no not_active Application Discontinuation
-
2006
- 2006-09-06 HK HK06109889A patent/HK1089443A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054136L (no) | Imidazol-4-yl-etynyl-pyridin-derivater | |
| CY1122238T1 (el) | Νεα 1-ναφθυλ-3-αζαδικυκλο[3.1.0]εξανia: παρασκευη και χρηση για τη θεραπεια νευροψυχιατρικων διαταραχων | |
| MA27134A1 (fr) | Derives diarylcycloalkyle, leur procede de preparation et leur utilisation en tant qu'activateurs des ppar | |
| NO20082768L (no) | Levodopa prodroge mesylat, sammensetninger og anvendelser derav | |
| NO20060328L (no) | Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser | |
| NO20056130L (no) | Nye substituerte 3-svovelindoler | |
| NO20083958L (no) | Prodrugs av GABA-analoger, sammensetninger og anvendelse derav | |
| NO20062303L (no) | Pyrazinderivater og farmasoytisk anvendelse derav | |
| CY1110745T1 (el) | Παραγωγα πυρρολιδονης ως αναστολεις μαοβ | |
| EA200500250A1 (ru) | Аналоги тиомолибдата и их применение | |
| WO2004071442A3 (en) | Novel bicyclic compounds and compositions | |
| NO20083197L (no) | Substituert cinnolin-derivater som GABAA-reseptor modulatorer og metode for deres syntese | |
| NO20060020L (no) | 3-fluorpiperidiner som NMDA/NR2B-antagonister | |
| WO2005123703A3 (en) | Alkynyl derivatives as modulators of metabotropic glutamate receptors | |
| ATE402176T1 (de) | Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten | |
| PL1706113T3 (pl) | Sposób wytwarzania chlorowodorku 4-(2-dipropyloaminoetylo)-1,3-dihydro-2H-indol-2-onu | |
| DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
| NO20082679L (no) | Sammensetning og fremgangsmate for a behandle CNS lidelser | |
| NO20056116L (no) | Tiowolframatanaloger og anvendelse av slike | |
| DK1272208T3 (da) | Anvendelse af VEGF 165 og homologer til at behandle neuron-sygdomme | |
| WO2007127393A3 (en) | Treatment and screening methods for promoting neurogenesis | |
| WO2007021575A3 (en) | Acetylenic piperazines as metabotropic glutamate receptor antagonists | |
| WO2022204362A3 (en) | Compositions and methods for treating a neurodegenerative or developmental disorder | |
| DOP2004000843A (es) | Derivados de imidazol-4-il-etinil-piridina | |
| NO20090812L (no) | Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |